Cargando…

“Dynamic Range” of Inferred Phenotypic HIV Drug Resistance Values in Clinical Practice

BACKGROUND: ‘Virtual’ or inferred phenotypes (vPhenotypes) are commonly used to assess resistance to antiretroviral agents in patients failing therapy. In this study, we provide a clinical context for understanding vPhenotype values. METHODS: All HIV-infected persons enrolled in the British Columbia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swenson, Luke C., Pollock, Graham, Wynhoven, Brian, Mo, Theresa, Dong, Winnie, Hogg, Robert S., Montaner, Julio S. G., Harrigan, P. Richard
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044728/ https://www.ncbi.nlm.nih.gov/pubmed/21390218 http://dx.doi.org/10.1371/journal.pone.0017402

Ejemplares similares

Technical and Regulatory Shortcomings of the TaqMan Version 1 HIV Viral Load Assay
por: Brumme, Chanson J., et al.
Publicado: (2012)

“Deep” Sequencing Accuracy and Reproducibility Using Roche/454 Technology for Inferring Co-Receptor Usage in HIV-1
por: Knapp, David J. H. F., et al.
Publicado: (2014)

Limited Evolution of Inferred HIV-1 Tropism while Viremia Is Undetectable during Standard HAART Therapy
por: Lee, Guinevere Q., et al.
Publicado: (2014)

Detection of Inferred CCR5- and CXCR4-Using HIV-1 Variants and Evolutionary Intermediates Using Ultra-Deep Pyrosequencing
por: Bunnik, Evelien M., et al.
Publicado: (2011)

Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study
por: Wood, Evan, et al.
Publicado: (2009)

Development and Validation of a Composite Programmatic Assessment Tool for HIV Therapy
por: Lima, Viviane D., et al.
Publicado: (2012)

Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS
por: Levy, Adrian R, et al.
Publicado: (2005)

Connection Domain Mutations N348I and A360V in HIV-1 Reverse Transcriptase Enhance Resistance to 3′-Azido-3′-deoxythymidine through Both RNase H-dependent and -independent Mechanisms
por: Ehteshami, Maryam, et al.
Publicado: (2008)

Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future
por: Harris, Marianne, et al.
Publicado: (2012)

Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1
por: Brumme, Zabrina L, et al.
Publicado: (2007)

Correction: Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1
por: Brumme, Zabrina L, et al.
Publicado: (2007)

Emergence of Drug Resistance Is Associated with an Increased Risk of Death among Patients First Starting HAART
por: Hogg, Robert S, et al.
Publicado: (2006)

Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study
por: Poon, Art F. Y., et al.
Publicado: (2016)

N348I in the Connection Domain of HIV-1 Reverse Transcriptase Confers Zidovudine and Nevirapine Resistance
por: Yap, Soo-Huey, et al.
Publicado: (2007)

Estimation of measurement error in plasma HIV-1 RNA assays near their limit of quantification
por: Lima, Viviane D., et al.
Publicado: (2017)

Calibration and accuracy of the geno2pheno co-receptor algorithm for predicting HIV tropism for single and triplicate measurements of V3 genotype
por: Swenson, LC, et al.
Publicado: (2010)

HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study
por: Harris, Marianne, et al.
Publicado: (2017)

Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting
por: Montaner, Julio S.G., et al.
Publicado: (2014)

Stroke and Systemic Thromboembolism Prevention in People Living With Human Immunodeficiency Virus With Atrial Fibrillation: A Review of Its Implications for Clinical Practice
por: Vizcarra, Pilar, et al.
Publicado: (2019)

Disparities in the Burden of HIV/AIDS in Canada
por: Hogg, Robert S., et al.
Publicado: (2012)

Relationship between Food Insecurity and Mortality among HIV-Positive Injection Drug Users Receiving Antiretroviral Therapy in British Columbia, Canada
por: Anema, Aranka, et al.
Publicado: (2013)

Correction: Disparities in the Burden of HIV/AIDS in Canada
por: Hogg, Robert S., et al.
Publicado: (2018)

A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015
por: Olding, Michelle, et al.
Publicado: (2017)

Short-term variation of HIV tropism readouts in the absence of CCR5 antagonists
por: Brumme, CJ, et al.
Publicado: (2010)

Physician's manual reporting underestimates mortality: evidence from a population-based HIV/AIDS treatment program
por: Au-Yeung, Christopher G, et al.
Publicado: (2010)

Application and Validation of Case-Finding Algorithms for Identifying Individuals with Human Immunodeficiency Virus from Administrative Data in British Columbia, Canada
por: Nosyk, Bohdan, et al.
Publicado: (2013)

The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada
por: Lima, Viviane Dias, et al.
Publicado: (2015)

Expanding HAART Treatment to All Currently Eligible Individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada
por: Lima, Viviane D., et al.
Publicado: (2010)

Reconstructing the Dynamics of HIV Evolution within Hosts from Serial Deep Sequence Data
por: Poon, Art F. Y., et al.
Publicado: (2012)

Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries
por: Raboud, Janet M, et al.
Publicado: (2010)

The Evolving Landscape of the Economics of HIV Treatment and Prevention
por: Nosyk, Bohdan, et al.
Publicado: (2012)

Prolonged and Substantial Discordance in Prevalence of Raltegravir-Resistant HIV-1 in Plasma versus PBMC Samples Revealed by 454 “Deep” Sequencing
por: Lee, Guinevere Q., et al.
Publicado: (2012)

Leveraging HIV Treatment to End AIDS, Stop New HIV Infections, and Avoid the Cost of Inaction
por: Sidibé, Michel, et al.
Publicado: (2014)

Improving practices and inferences in developmental cognitive neuroscience
por: Flournoy, John C., et al.
Publicado: (2020)

Disability-adjusted life years associated with chronic comorbidities among people living with and without HIV: Estimating health burden in British Columbia, Canada
por: Nanditha, Ni Gusti Ayu, et al.
Publicado: (2022)

Practical inferences
por: Hare, R. M. (Richard Mervyn)
Publicado: (1972)

Theoretical and experimental assessment of degenerate primer tagging in ultra-deep applications of next-generation sequencing
por: Liang, Richard H., et al.
Publicado: (2014)

HIV/AIDS in Vancouver, British Columbia: a growing epidemic
por: McInnes, Colin W, et al.
Publicado: (2009)

Virologic suppression and mortality of patients who migrate for HIV care in the province of British Columbia, Canada, from 2003 to 2012: a retrospective cohort study
por: Lima, Viviane Dias, et al.
Publicado: (2015)

Tuberculosis mortality in HIV-infected individuals: a cross-national systematic assessment
por: Au-Yeung, Christopher, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ln555p33v0006206kgmbrad768